JD Health International Inc.
JD Health International Inc. (JDHIF) Revenue
Annual & quarterly revenue history · segment & region breakdown
JDHIF · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsJD Health International Inc. trailing twelve-month (TTM) revenue is $131B, an increase of 23.02% year-over-year from $71.55B in FY2025.
Revenue trend
2025 – 2017 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $71.55B | +$13.39B | +23.02% |
| 2024-12-31 | $58.16B | +$4.63B | +8.65% |
| 2023-12-31 | $53.53B | +$6.79B | +14.54% |
| 2022-12-31 | $46.74B | +$16.05B | +52.32% |
| 2021-12-31 | $30.68B | +$11.30B | +58.30% |
| 2020-12-31 | $19.38B | +$8.54B | +78.77% |
| 2019-12-31 | $10.84B | +$2.67B | +32.72% |
| 2018-12-31 | $8.17B | +$2.62B | +47.11% |
| 2017-12-31 | $5.55B | — | — |
Compare revenue vs peers
Medical - Care FacilitiesCompare JDHIF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income JD Health International Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
JD Health International Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CNY.
Data sourced from JD Health International Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
JDHIF revenue · 4 questionsJDHIF's trailing twelve-month (TTM) revenue is $131B. That is an increase of 23.02% year-over-year from $71.55B in FY2025.
▸ Source: FMP · JD Health International Inc. SEC filings · GAAP · JD Health International Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026